BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 15, 2004
View Archived Issues
Antares Pharma announces agreement with ProSkelia
Read More
BattellePharma now Ventaira Pharmaceuticals
Read More
Celltech Group achieves milestone in osteoporosis collaboration with Amgen
Read More
Genome Therapeutics and Amgen conclude research agreement
Read More
Pierre Fabre presents protein prenyltransferase inhibitors for cancer and other disorders
Read More
Almirall Prodesfarma identifies new H1 antagonists with good selectivity profile
Read More
Novel orally bioavailable VLA-4 antagonists under study at Elan
Read More
BMS scientists claim Eg5 inhibitors and their use in cancer therapy
Read More
Chiron expands its phase II program for IL-2 in the treatment of lymphoma
Read More
Glycopeptide-cephalosporin conjugates prepared and tested at Theravance
Read More
Sanofi-Synthelabo presents beta3-AR agonists for GI disorders and other uses
Read More
Allergan claims novel alpha2-AR agonists with potential as analgesic agents
Read More
Thios licenses rPSGL-Ig from Wyeth
Read More
Medicure looks back at milestone developments
Read More
Archemix and Nuvelo enter development agreement for ARC-183
Read More
Kemin Pharma develops two new molecules for HCV
Read More
Eloxatin approved for first-line treatment of advanced colorectal cancer
Read More
BioStratum and Novo Nordisk to develop antibodies to laminin-5 for cancer
Read More
Approvable letter for Cipher's fenofibrate formulation
Read More
Phase III R-modafinil program progresses towards Q4 NDA filing
Read More
MPI-176716 produces tumor regression in animal models of ovarian cancer
Read More
Schering-Plough/Pharmacopeia collaborative compound enters clinical trials
Read More
New phase I trial for Traficet-EN
Read More
Phase II trial confirms icatibant utility in hereditary angioedema
Read More
Second pivotal trial of methylnaltrexone for opioid-induced constipation
Read More
Namenda available for moderate to severe Alzheimer's disease
Read More
Significant improvements reported for tacrolimus ointment in cutaneous lupus erythematosus
Read More
Eszopiclone improves sleep onset, maintenance and quality in patients with chronic insomnia
Read More
Low-dose DHEA supplements improve endocrine parameters in postmenopausal women
Read More
Identification of anthrax lethal factor inhibitors
Read More
Novel class of farnesyltransferase inhibitors synthesized by Abbott
Read More